Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Negative-Pressure Wound Therapy | 27 | 2023 | 156 | 8.660 |
Why?
|
Wound Healing | 102 | 2024 | 2819 | 8.140 |
Why?
|
Tissue Expansion | 17 | 2020 | 163 | 5.660 |
Why?
|
Adipose Tissue | 24 | 2023 | 3335 | 4.200 |
Why?
|
Diabetic Foot | 22 | 2024 | 383 | 4.020 |
Why?
|
Skin, Artificial | 18 | 2023 | 89 | 3.840 |
Why?
|
Wounds and Injuries | 28 | 2021 | 2518 | 3.300 |
Why?
|
Hidradenitis Suppurativa | 9 | 2024 | 179 | 3.280 |
Why?
|
Neovascularization, Physiologic | 28 | 2022 | 1369 | 3.240 |
Why?
|
Surgical Flaps | 41 | 2024 | 1683 | 3.190 |
Why?
|
Skin Transplantation | 33 | 2022 | 1097 | 3.150 |
Why?
|
Surgery, Plastic | 16 | 2019 | 650 | 2.940 |
Why?
|
Mammaplasty | 21 | 2024 | 1262 | 2.870 |
Why?
|
Skin | 41 | 2024 | 4520 | 2.610 |
Why?
|
Burns | 29 | 2024 | 1887 | 2.520 |
Why?
|
Tissue Scaffolds | 12 | 2021 | 948 | 2.280 |
Why?
|
Adipogenesis | 6 | 2022 | 370 | 2.250 |
Why?
|
Glycosaminoglycans | 17 | 2021 | 611 | 2.230 |
Why?
|
Adipocytes | 7 | 2021 | 1199 | 2.020 |
Why?
|
Surgical Wound Infection | 13 | 2022 | 1544 | 1.990 |
Why?
|
Dermis | 9 | 2022 | 204 | 1.900 |
Why?
|
Tissue Engineering | 12 | 2021 | 1890 | 1.890 |
Why?
|
Collagen | 28 | 2022 | 2646 | 1.840 |
Why?
|
Sternotomy | 4 | 2021 | 132 | 1.550 |
Why?
|
Diabetes Mellitus, Experimental | 17 | 2023 | 1121 | 1.520 |
Why?
|
Tissue Expansion Devices | 5 | 2019 | 160 | 1.480 |
Why?
|
Wound Closure Techniques | 4 | 2021 | 88 | 1.480 |
Why?
|
Diabetes Mellitus | 19 | 2024 | 5887 | 1.410 |
Why?
|
Free Tissue Flaps | 6 | 2024 | 337 | 1.410 |
Why?
|
Diabetes Complications | 7 | 2013 | 1322 | 1.400 |
Why?
|
Subcutaneous Fat | 5 | 2019 | 402 | 1.400 |
Why?
|
Regeneration | 14 | 2019 | 1527 | 1.400 |
Why?
|
Epidermis | 9 | 2014 | 539 | 1.370 |
Why?
|
Bandages | 10 | 2021 | 273 | 1.360 |
Why?
|
Postoperative Care | 5 | 2021 | 1481 | 1.280 |
Why?
|
Publishing | 9 | 2021 | 836 | 1.250 |
Why?
|
Acetylglucosamine | 4 | 2011 | 189 | 1.250 |
Why?
|
Guidelines as Topic | 7 | 2018 | 1395 | 1.180 |
Why?
|
Granulation Tissue | 13 | 2013 | 92 | 1.170 |
Why?
|
Cosmetic Techniques | 3 | 2021 | 149 | 1.120 |
Why?
|
Lymphedema | 4 | 2023 | 527 | 1.120 |
Why?
|
Keratinocytes | 7 | 2021 | 879 | 1.100 |
Why?
|
Surgical Mesh | 4 | 2018 | 316 | 1.080 |
Why?
|
Postoperative Complications | 32 | 2024 | 15879 | 1.050 |
Why?
|
Keloid | 2 | 2019 | 55 | 1.000 |
Why?
|
Surgical Procedures, Operative | 7 | 2018 | 1937 | 0.990 |
Why?
|
Absorbable Implants | 3 | 2019 | 339 | 0.960 |
Why?
|
Cell Proliferation | 29 | 2020 | 10490 | 0.960 |
Why?
|
Skin Ulcer | 4 | 2016 | 131 | 0.950 |
Why?
|
Stress, Mechanical | 7 | 2019 | 1680 | 0.950 |
Why?
|
Varicose Ulcer | 3 | 2022 | 55 | 0.920 |
Why?
|
Skin Physiological Phenomena | 7 | 2014 | 194 | 0.920 |
Why?
|
Ketorolac | 2 | 2015 | 95 | 0.890 |
Why?
|
Omentum | 3 | 2013 | 168 | 0.860 |
Why?
|
Sternum | 4 | 2021 | 177 | 0.840 |
Why?
|
Debridement | 8 | 2021 | 494 | 0.830 |
Why?
|
Subcutaneous Tissue | 2 | 2013 | 132 | 0.800 |
Why?
|
Adiposity | 2 | 2024 | 1888 | 0.790 |
Why?
|
General Surgery | 8 | 2019 | 1714 | 0.790 |
Why?
|
Pressure Ulcer | 3 | 2020 | 159 | 0.790 |
Why?
|
Humans | 252 | 2024 | 768369 | 0.780 |
Why?
|
Tissue and Organ Harvesting | 3 | 2014 | 374 | 0.780 |
Why?
|
Polyurethanes | 5 | 2022 | 110 | 0.770 |
Why?
|
Adipokines | 1 | 2024 | 309 | 0.770 |
Why?
|
Animals | 106 | 2023 | 169424 | 0.750 |
Why?
|
Mice | 66 | 2023 | 82051 | 0.740 |
Why?
|
Breast Implants | 5 | 2024 | 414 | 0.730 |
Why?
|
Lipectomy | 1 | 2022 | 115 | 0.730 |
Why?
|
Seroma | 3 | 2022 | 74 | 0.730 |
Why?
|
Suction | 8 | 2022 | 268 | 0.720 |
Why?
|
Endothelial Cells | 10 | 2021 | 3586 | 0.720 |
Why?
|
Postoperative Hemorrhage | 2 | 2015 | 420 | 0.720 |
Why?
|
Cicatrix | 9 | 2022 | 799 | 0.710 |
Why?
|
Occlusive Dressings | 8 | 2014 | 52 | 0.710 |
Why?
|
Graft Survival | 11 | 2021 | 3890 | 0.700 |
Why?
|
Blood Platelets | 6 | 2008 | 2485 | 0.700 |
Why?
|
Penile Diseases | 1 | 2020 | 47 | 0.690 |
Why?
|
Scrotum | 1 | 2020 | 117 | 0.670 |
Why?
|
Chemokine CXCL12 | 3 | 2018 | 457 | 0.670 |
Why?
|
Transplantation, Autologous | 11 | 2021 | 2126 | 0.670 |
Why?
|
Research Design | 7 | 2017 | 6217 | 0.670 |
Why?
|
Prone Position | 1 | 2020 | 203 | 0.660 |
Why?
|
Platelet-Rich Plasma | 3 | 2021 | 181 | 0.650 |
Why?
|
Mesenchymal Stem Cells | 6 | 2022 | 1671 | 0.650 |
Why?
|
Cicatrix, Hypertrophic | 2 | 2019 | 80 | 0.650 |
Why?
|
Hernia, Ventral | 3 | 2015 | 220 | 0.640 |
Why?
|
Mechanotransduction, Cellular | 3 | 2021 | 542 | 0.630 |
Why?
|
Extracellular Matrix | 7 | 2018 | 1737 | 0.600 |
Why?
|
Equipment and Supplies | 1 | 2020 | 273 | 0.590 |
Why?
|
Medical Tourism | 1 | 2018 | 52 | 0.580 |
Why?
|
Ephedrine | 1 | 2017 | 52 | 0.570 |
Why?
|
Fibroblasts | 7 | 2021 | 4180 | 0.570 |
Why?
|
Technology | 1 | 2020 | 296 | 0.570 |
Why?
|
Surgical Wound Dehiscence | 1 | 2019 | 216 | 0.570 |
Why?
|
Fractures, Open | 2 | 2010 | 107 | 0.570 |
Why?
|
Radiation Injuries | 2 | 2023 | 1205 | 0.570 |
Why?
|
Facial Injuries | 8 | 2022 | 191 | 0.570 |
Why?
|
Delphi Technique | 13 | 2024 | 879 | 0.560 |
Why?
|
Mice, Inbred C57BL | 30 | 2022 | 22365 | 0.550 |
Why?
|
Mice, Inbred Strains | 9 | 2018 | 1770 | 0.550 |
Why?
|
Abdominal Wall | 1 | 2018 | 167 | 0.540 |
Why?
|
Tryptases | 2 | 2014 | 176 | 0.540 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2024 | 10358 | 0.530 |
Why?
|
Clinical Protocols | 5 | 2024 | 1444 | 0.530 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2017 | 146 | 0.530 |
Why?
|
Biological Products | 2 | 2023 | 937 | 0.530 |
Why?
|
Male | 129 | 2024 | 364761 | 0.520 |
Why?
|
Facial Nerve Injuries | 1 | 2016 | 64 | 0.510 |
Why?
|
Freeze Drying | 4 | 2008 | 97 | 0.510 |
Why?
|
Evidence-Based Medicine | 8 | 2021 | 3708 | 0.510 |
Why?
|
Transplantation, Homologous | 7 | 2019 | 4834 | 0.510 |
Why?
|
Vacuum | 5 | 2011 | 65 | 0.510 |
Why?
|
Angiogenesis Inducing Agents | 2 | 2008 | 254 | 0.500 |
Why?
|
Pressure | 2 | 2017 | 1173 | 0.480 |
Why?
|
Publications | 1 | 2017 | 196 | 0.480 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 562 | 0.480 |
Why?
|
Chymases | 1 | 2014 | 84 | 0.470 |
Why?
|
Female | 126 | 2024 | 396926 | 0.470 |
Why?
|
Implant Capsular Contracture | 1 | 2014 | 23 | 0.470 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 2279 | 0.470 |
Why?
|
Perfusion | 2 | 2018 | 1402 | 0.460 |
Why?
|
Silicone Elastomers | 3 | 2014 | 78 | 0.460 |
Why?
|
Stromal Cells | 2 | 2018 | 1335 | 0.460 |
Why?
|
Platelet Transfusion | 3 | 2007 | 301 | 0.460 |
Why?
|
Lower Extremity | 4 | 2024 | 1214 | 0.460 |
Why?
|
Pain, Postoperative | 2 | 2015 | 1763 | 0.450 |
Why?
|
Mastectomy | 9 | 2024 | 1852 | 0.450 |
Why?
|
Hydrostatic Pressure | 2 | 2014 | 99 | 0.440 |
Why?
|
Random Allocation | 7 | 2019 | 2399 | 0.440 |
Why?
|
Clinical Competence | 9 | 2016 | 4841 | 0.440 |
Why?
|
Tensile Strength | 3 | 2011 | 335 | 0.440 |
Why?
|
Review Literature as Topic | 1 | 2016 | 354 | 0.440 |
Why?
|
Intraoperative Care | 2 | 2017 | 772 | 0.440 |
Why?
|
Vasoconstrictor Agents | 1 | 2017 | 658 | 0.440 |
Why?
|
Hypoalbuminemia | 2 | 2024 | 90 | 0.440 |
Why?
|
Neovascularization, Pathologic | 8 | 2022 | 2643 | 0.440 |
Why?
|
Wounds, Penetrating | 2 | 2012 | 316 | 0.420 |
Why?
|
Disease Models, Animal | 18 | 2020 | 18390 | 0.420 |
Why?
|
Vascular Endothelial Growth Factor A | 11 | 2022 | 3520 | 0.410 |
Why?
|
Soft Tissue Injuries | 6 | 2022 | 173 | 0.410 |
Why?
|
Facial Paralysis | 3 | 2023 | 346 | 0.410 |
Why?
|
Leg Ulcer | 3 | 2022 | 71 | 0.400 |
Why?
|
Lymph | 1 | 2012 | 78 | 0.390 |
Why?
|
Medical Records | 5 | 2017 | 1413 | 0.390 |
Why?
|
Monitoring, Physiologic | 2 | 2014 | 1795 | 0.390 |
Why?
|
Breast Neoplasms | 13 | 2024 | 21157 | 0.390 |
Why?
|
Personal Satisfaction | 1 | 2016 | 648 | 0.390 |
Why?
|
Mast Cells | 4 | 2016 | 1407 | 0.390 |
Why?
|
Ultrasonography, Doppler | 1 | 2014 | 463 | 0.380 |
Why?
|
Burns, Electric | 3 | 2015 | 40 | 0.380 |
Why?
|
High-Energy Shock Waves | 1 | 2011 | 33 | 0.380 |
Why?
|
Cardiac Surgical Procedures | 2 | 2021 | 3682 | 0.380 |
Why?
|
Immunohistochemistry | 14 | 2014 | 11139 | 0.370 |
Why?
|
Transforming Growth Factor alpha | 1 | 2011 | 135 | 0.360 |
Why?
|
Meta-Analysis as Topic | 1 | 2016 | 1364 | 0.360 |
Why?
|
Neuropeptides | 3 | 2013 | 950 | 0.360 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2011 | 71 | 0.360 |
Why?
|
Retrospective Studies | 43 | 2024 | 81835 | 0.350 |
Why?
|
Nerve Regeneration | 1 | 2016 | 801 | 0.350 |
Why?
|
Cartilage | 3 | 2014 | 808 | 0.350 |
Why?
|
Microsurgery | 5 | 2009 | 803 | 0.350 |
Why?
|
Intraoperative Complications | 1 | 2017 | 1176 | 0.350 |
Why?
|
Registries | 2 | 2017 | 8372 | 0.340 |
Why?
|
Collagen Type I | 3 | 2011 | 620 | 0.340 |
Why?
|
Guideline Adherence | 1 | 2020 | 2239 | 0.340 |
Why?
|
Trehalose | 2 | 2007 | 88 | 0.340 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 823 | 0.340 |
Why?
|
Osteosarcoma | 1 | 2016 | 912 | 0.340 |
Why?
|
Stem Cells | 4 | 2014 | 3538 | 0.330 |
Why?
|
Quality Improvement | 7 | 2023 | 3858 | 0.330 |
Why?
|
Hematoma | 2 | 2019 | 768 | 0.320 |
Why?
|
Middle Aged | 70 | 2024 | 223406 | 0.320 |
Why?
|
Serine Endopeptidases | 1 | 2014 | 1032 | 0.320 |
Why?
|
Hematopoietic Stem Cells | 3 | 2018 | 3408 | 0.320 |
Why?
|
Mouth Mucosa | 2 | 2002 | 437 | 0.320 |
Why?
|
Treatment Outcome | 35 | 2024 | 65408 | 0.320 |
Why?
|
Leg | 4 | 2009 | 1089 | 0.320 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2011 | 284 | 0.320 |
Why?
|
Practice Guidelines as Topic | 8 | 2019 | 7449 | 0.310 |
Why?
|
Antigens, CD1 | 2 | 2021 | 434 | 0.300 |
Why?
|
Fibula | 3 | 2010 | 270 | 0.300 |
Why?
|
Research Report | 2 | 2019 | 369 | 0.300 |
Why?
|
Physical Examination | 1 | 2014 | 1262 | 0.290 |
Why?
|
Prosthesis Design | 2 | 2014 | 2126 | 0.290 |
Why?
|
Cell Cycle | 1 | 2016 | 2942 | 0.290 |
Why?
|
Adult | 67 | 2024 | 223528 | 0.290 |
Why?
|
Actins | 3 | 2012 | 2064 | 0.290 |
Why?
|
Platelet-Derived Growth Factor | 3 | 2007 | 617 | 0.280 |
Why?
|
Consensus | 10 | 2024 | 3207 | 0.280 |
Why?
|
Bronchial Fistula | 2 | 2023 | 83 | 0.280 |
Why?
|
Tibial Fractures | 2 | 2010 | 276 | 0.280 |
Why?
|
Prostheses and Implants | 1 | 2014 | 1279 | 0.280 |
Why?
|
Thigh | 2 | 2008 | 239 | 0.280 |
Why?
|
Accidents, Occupational | 2 | 1999 | 252 | 0.270 |
Why?
|
Biocompatible Materials | 4 | 2019 | 1703 | 0.270 |
Why?
|
Nerve Fibers | 1 | 2010 | 708 | 0.270 |
Why?
|
Pleural Diseases | 2 | 2023 | 138 | 0.270 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 4582 | 0.270 |
Why?
|
Obesity | 5 | 2024 | 13065 | 0.270 |
Why?
|
Hot Temperature | 3 | 2005 | 1438 | 0.270 |
Why?
|
MicroRNAs | 5 | 2021 | 3806 | 0.260 |
Why?
|
Femoral Artery | 3 | 2008 | 829 | 0.260 |
Why?
|
Pandemics | 3 | 2021 | 8751 | 0.260 |
Why?
|
Facial Transplantation | 3 | 2015 | 222 | 0.260 |
Why?
|
Cohort Studies | 10 | 2024 | 41782 | 0.260 |
Why?
|
Abdominal Muscles | 2 | 2011 | 172 | 0.250 |
Why?
|
Models, Animal | 4 | 2017 | 2126 | 0.250 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2022 | 507 | 0.250 |
Why?
|
Learning Curve | 4 | 2016 | 233 | 0.250 |
Why?
|
Wounds, Nonpenetrating | 3 | 2016 | 813 | 0.250 |
Why?
|
Blood Preservation | 2 | 2007 | 169 | 0.250 |
Why?
|
Standard of Care | 5 | 2024 | 571 | 0.250 |
Why?
|
Esthetics | 4 | 2018 | 329 | 0.250 |
Why?
|
Keratins | 2 | 2024 | 502 | 0.240 |
Why?
|
Foot | 3 | 2022 | 577 | 0.240 |
Why?
|
Thermography | 1 | 2005 | 63 | 0.240 |
Why?
|
Rats, Inbred Lew | 2 | 2017 | 1165 | 0.240 |
Why?
|
Groin | 2 | 2008 | 107 | 0.240 |
Why?
|
Regional Blood Flow | 4 | 2013 | 1503 | 0.240 |
Why?
|
Quality of Life | 10 | 2024 | 13497 | 0.230 |
Why?
|
Vascular Patency | 1 | 2008 | 916 | 0.230 |
Why?
|
Amnion | 3 | 2022 | 202 | 0.230 |
Why?
|
Lymph Nodes | 2 | 2019 | 3472 | 0.230 |
Why?
|
Diffusion of Innovation | 2 | 2016 | 730 | 0.230 |
Why?
|
Swine | 12 | 2022 | 5996 | 0.230 |
Why?
|
Decompression, Surgical | 1 | 2009 | 612 | 0.230 |
Why?
|
Wound Infection | 2 | 2005 | 244 | 0.230 |
Why?
|
Aged | 47 | 2024 | 171514 | 0.230 |
Why?
|
Therapeutic Irrigation | 2 | 2021 | 297 | 0.220 |
Why?
|
Dermatomycoses | 1 | 2004 | 48 | 0.220 |
Why?
|
Bone Marrow Cells | 2 | 2014 | 2415 | 0.220 |
Why?
|
Basement Membrane | 1 | 2005 | 349 | 0.220 |
Why?
|
Tissue Adhesions | 3 | 2016 | 223 | 0.220 |
Why?
|
Cell Hypoxia | 3 | 2019 | 661 | 0.220 |
Why?
|
Scalp Dermatoses | 1 | 2004 | 44 | 0.220 |
Why?
|
Amiodarone | 1 | 2005 | 217 | 0.220 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2562 | 0.220 |
Why?
|
Matrix Metalloproteinases | 1 | 2006 | 394 | 0.220 |
Why?
|
Specialties, Surgical | 4 | 2018 | 393 | 0.220 |
Why?
|
Length of Stay | 5 | 2022 | 6521 | 0.210 |
Why?
|
Bell Palsy | 1 | 2023 | 39 | 0.210 |
Why?
|
Education, Medical, Continuing | 2 | 2013 | 829 | 0.210 |
Why?
|
Skull Fractures | 2 | 2022 | 203 | 0.210 |
Why?
|
Rats | 7 | 2019 | 23839 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.210 |
Why?
|
Thoracotomy | 1 | 2004 | 375 | 0.210 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 61 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
Culture Media | 2 | 2001 | 899 | 0.200 |
Why?
|
Chorion | 2 | 2022 | 112 | 0.200 |
Why?
|
Efficiency | 3 | 2015 | 477 | 0.200 |
Why?
|
Nomograms | 1 | 2024 | 236 | 0.200 |
Why?
|
Lung Diseases, Fungal | 1 | 2003 | 125 | 0.200 |
Why?
|
Thoracic Injuries | 1 | 2005 | 291 | 0.200 |
Why?
|
Ultraviolet Rays | 1 | 2007 | 1100 | 0.200 |
Why?
|
Prospective Studies | 21 | 2024 | 54913 | 0.200 |
Why?
|
Mice, Hairless | 3 | 2017 | 39 | 0.200 |
Why?
|
Mycosis Fungoides | 1 | 2023 | 170 | 0.190 |
Why?
|
Aged, 80 and over | 21 | 2024 | 59679 | 0.190 |
Why?
|
Vascular Diseases | 2 | 2008 | 1162 | 0.190 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 369 | 0.190 |
Why?
|
Body Temperature | 1 | 2005 | 781 | 0.190 |
Why?
|
Periodicals as Topic | 3 | 2017 | 1468 | 0.190 |
Why?
|
Chronic Disease | 6 | 2021 | 9379 | 0.190 |
Why?
|
Patient Care Team | 5 | 2016 | 2526 | 0.190 |
Why?
|
Bone Wires | 1 | 2021 | 125 | 0.190 |
Why?
|
Prostatic Diseases | 1 | 2001 | 57 | 0.190 |
Why?
|
Nanofibers | 2 | 2011 | 68 | 0.190 |
Why?
|
Finite Element Analysis | 3 | 2010 | 441 | 0.190 |
Why?
|
Venous Thrombosis | 2 | 2008 | 1317 | 0.190 |
Why?
|
Body Surface Area | 1 | 2002 | 207 | 0.190 |
Why?
|
Aspergillosis | 1 | 2003 | 242 | 0.180 |
Why?
|
Reoperation | 8 | 2024 | 4342 | 0.180 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2005 | 775 | 0.180 |
Why?
|
Mice, Inbred NOD | 4 | 2019 | 1840 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2023 | 12242 | 0.180 |
Why?
|
Ki-67 Antigen | 3 | 2011 | 631 | 0.180 |
Why?
|
Rectal Fistula | 1 | 2001 | 76 | 0.180 |
Why?
|
Epithelium | 4 | 2011 | 1610 | 0.180 |
Why?
|
Arterial Occlusive Diseases | 1 | 2005 | 751 | 0.180 |
Why?
|
Leg Injuries | 2 | 2022 | 180 | 0.180 |
Why?
|
Hypopigmentation | 1 | 2001 | 43 | 0.180 |
Why?
|
Heparin | 1 | 2008 | 1636 | 0.180 |
Why?
|
Gelatin | 2 | 2019 | 230 | 0.170 |
Why?
|
Microscopy, Confocal | 2 | 2017 | 1977 | 0.170 |
Why?
|
Oxandrolone | 1 | 2000 | 24 | 0.170 |
Why?
|
Cells, Cultured | 8 | 2019 | 19035 | 0.170 |
Why?
|
Flow Cytometry | 5 | 2017 | 5893 | 0.170 |
Why?
|
Middle East | 1 | 2020 | 232 | 0.170 |
Why?
|
Delayed-Action Preparations | 1 | 2024 | 969 | 0.170 |
Why?
|
Computer Graphics | 1 | 2002 | 338 | 0.170 |
Why?
|
Aftercare | 3 | 2024 | 921 | 0.170 |
Why?
|
Biomedical Research | 1 | 2015 | 3463 | 0.170 |
Why?
|
Plasma | 3 | 2008 | 586 | 0.170 |
Why?
|
Parabiosis | 2 | 2010 | 65 | 0.170 |
Why?
|
Cell Extracts | 1 | 2020 | 135 | 0.170 |
Why?
|
Membrane Lipids | 1 | 2021 | 251 | 0.170 |
Why?
|
Administration, Topical | 4 | 2019 | 707 | 0.170 |
Why?
|
Fistula | 1 | 2001 | 213 | 0.170 |
Why?
|
Rhinoplasty | 1 | 2023 | 239 | 0.170 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2021 | 190 | 0.170 |
Why?
|
Combined Modality Therapy | 3 | 2021 | 8559 | 0.170 |
Why?
|
Glutaral | 3 | 2007 | 78 | 0.170 |
Why?
|
Risk Assessment | 12 | 2024 | 24310 | 0.170 |
Why?
|
Cell Membrane | 3 | 2021 | 3663 | 0.160 |
Why?
|
Incidental Findings | 1 | 2004 | 699 | 0.160 |
Why?
|
Guided Tissue Regeneration | 1 | 2019 | 88 | 0.160 |
Why?
|
Fracture Fixation, Internal | 1 | 2006 | 981 | 0.160 |
Why?
|
Materials Testing | 2 | 2017 | 871 | 0.160 |
Why?
|
Kinetics | 4 | 2013 | 6347 | 0.160 |
Why?
|
Ischemic Postconditioning | 1 | 2019 | 24 | 0.160 |
Why?
|
Cell Differentiation | 5 | 2019 | 11674 | 0.160 |
Why?
|
Vascular Surgical Procedures | 2 | 2023 | 1509 | 0.160 |
Why?
|
Melanins | 1 | 2001 | 290 | 0.160 |
Why?
|
Bone Plates | 1 | 2021 | 468 | 0.150 |
Why?
|
Sarcopenia | 1 | 2023 | 376 | 0.150 |
Why?
|
5-Methylcytosine | 1 | 2019 | 148 | 0.150 |
Why?
|
Mastectomy, Subcutaneous | 1 | 2018 | 56 | 0.150 |
Why?
|
Anti-Bacterial Agents | 4 | 2021 | 7467 | 0.150 |
Why?
|
Education, Distance | 1 | 2002 | 261 | 0.150 |
Why?
|
Ischemic Preconditioning | 1 | 2018 | 89 | 0.150 |
Why?
|
Quadriceps Muscle | 1 | 2019 | 157 | 0.150 |
Why?
|
Nipples | 2 | 2018 | 230 | 0.150 |
Why?
|
Analysis of Variance | 3 | 2016 | 6242 | 0.150 |
Why?
|
Time Factors | 12 | 2020 | 40271 | 0.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2018 | 5708 | 0.150 |
Why?
|
Patient Positioning | 1 | 2020 | 332 | 0.150 |
Why?
|
Anticoagulants | 2 | 2016 | 4835 | 0.150 |
Why?
|
Caveolin 1 | 1 | 2019 | 255 | 0.140 |
Why?
|
Edema | 2 | 2013 | 766 | 0.140 |
Why?
|
Anabolic Agents | 1 | 2000 | 256 | 0.140 |
Why?
|
Melanocytes | 1 | 2001 | 512 | 0.140 |
Why?
|
Biomimetic Materials | 1 | 2019 | 173 | 0.140 |
Why?
|
Databases, Factual | 7 | 2024 | 8081 | 0.140 |
Why?
|
Risk Factors | 15 | 2024 | 74915 | 0.140 |
Why?
|
Guinea Pigs | 7 | 2004 | 1310 | 0.140 |
Why?
|
Sensitivity and Specificity | 4 | 2016 | 14725 | 0.140 |
Why?
|
Dioxygenases | 1 | 2019 | 351 | 0.130 |
Why?
|
Graft Rejection | 4 | 2018 | 4505 | 0.130 |
Why?
|
Critical Care | 1 | 2009 | 2717 | 0.130 |
Why?
|
Blotting, Western | 2 | 2016 | 5042 | 0.130 |
Why?
|
Cross-Linking Reagents | 3 | 2007 | 692 | 0.130 |
Why?
|
Bone Substitutes | 1 | 1998 | 233 | 0.130 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2019 | 706 | 0.130 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2016 | 87 | 0.130 |
Why?
|
Arthroplasty, Replacement, Knee | 3 | 2016 | 1401 | 0.130 |
Why?
|
Smad1 Protein | 1 | 2016 | 81 | 0.130 |
Why?
|
Otorhinolaryngologic Neoplasms | 1 | 2015 | 26 | 0.130 |
Why?
|
Urinary Bladder | 1 | 2022 | 1160 | 0.130 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 682 | 0.130 |
Why?
|
Ascorbic Acid | 1 | 2019 | 658 | 0.130 |
Why?
|
Adipose Tissue, Brown | 1 | 2021 | 776 | 0.130 |
Why?
|
Protein Kinase C-delta | 1 | 2016 | 115 | 0.130 |
Why?
|
Inflammation | 8 | 2022 | 10863 | 0.130 |
Why?
|
Forecasting | 2 | 2016 | 2950 | 0.130 |
Why?
|
Arrhythmias, Cardiac | 1 | 2005 | 2258 | 0.120 |
Why?
|
Hemostatics | 1 | 1998 | 247 | 0.120 |
Why?
|
Porosity | 3 | 2017 | 352 | 0.120 |
Why?
|
Insulin Resistance | 2 | 2021 | 3974 | 0.120 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2021 | 2564 | 0.120 |
Why?
|
Medical Informatics | 1 | 2002 | 737 | 0.120 |
Why?
|
T-Lymphocytes | 3 | 2021 | 10269 | 0.120 |
Why?
|
Models, Statistical | 1 | 2009 | 5103 | 0.120 |
Why?
|
Hemangiosarcoma | 1 | 2017 | 216 | 0.120 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 2 | 2017 | 934 | 0.120 |
Why?
|
Mastectomy, Segmental | 2 | 2017 | 961 | 0.110 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2016 | 946 | 0.110 |
Why?
|
Neck | 1 | 1999 | 736 | 0.110 |
Why?
|
Electrosurgery | 1 | 2014 | 53 | 0.110 |
Why?
|
History, 21st Century | 2 | 2021 | 1575 | 0.110 |
Why?
|
Facial Muscles | 1 | 1995 | 159 | 0.110 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2016 | 558 | 0.110 |
Why?
|
Fractures, Bone | 1 | 2006 | 2063 | 0.110 |
Why?
|
Breast | 2 | 2018 | 1976 | 0.110 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2785 | 0.110 |
Why?
|
Follow-Up Studies | 14 | 2024 | 39429 | 0.110 |
Why?
|
Cysteine Endopeptidases | 1 | 1996 | 551 | 0.110 |
Why?
|
Cell Division | 4 | 2008 | 4479 | 0.110 |
Why?
|
Elbow | 1 | 1994 | 130 | 0.110 |
Why?
|
Myometrium | 1 | 2014 | 174 | 0.110 |
Why?
|
Gels | 1 | 2014 | 421 | 0.110 |
Why?
|
Young Adult | 11 | 2024 | 60038 | 0.110 |
Why?
|
Atmospheric Pressure | 2 | 2006 | 48 | 0.110 |
Why?
|
Hyaluronic Acid | 1 | 2017 | 489 | 0.110 |
Why?
|
Explosions | 1 | 2013 | 107 | 0.110 |
Why?
|
Necrosis | 4 | 2022 | 1622 | 0.110 |
Why?
|
Inpatients | 3 | 2022 | 2561 | 0.110 |
Why?
|
Oligonucleotides, Antisense | 1 | 2016 | 462 | 0.110 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2017 | 555 | 0.110 |
Why?
|
Chondrogenesis | 1 | 2014 | 239 | 0.100 |
Why?
|
Biophysical Phenomena | 1 | 2013 | 321 | 0.100 |
Why?
|
Lasers, Gas | 1 | 2014 | 101 | 0.100 |
Why?
|
Catheterization | 2 | 2011 | 1431 | 0.100 |
Why?
|
Embryonic Stem Cells | 1 | 2020 | 1249 | 0.100 |
Why?
|
Face | 1 | 1999 | 1031 | 0.100 |
Why?
|
Polymers | 1 | 2020 | 1631 | 0.100 |
Why?
|
MAP Kinase Signaling System | 1 | 2020 | 1489 | 0.100 |
Why?
|
Ear, External | 2 | 2007 | 165 | 0.100 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2014 | 321 | 0.100 |
Why?
|
Injury Severity Score | 2 | 2020 | 1053 | 0.100 |
Why?
|
Coronary Artery Bypass | 3 | 2015 | 2194 | 0.100 |
Why?
|
Mice, SCID | 1 | 2017 | 2633 | 0.100 |
Why?
|
Surgery Department, Hospital | 1 | 2013 | 176 | 0.100 |
Why?
|
History, 20th Century | 2 | 2021 | 2772 | 0.100 |
Why?
|
Blood Transfusion | 1 | 2019 | 1308 | 0.100 |
Why?
|
Polyethylene Glycols | 1 | 1998 | 1195 | 0.100 |
Why?
|
Rabbits | 3 | 2005 | 4786 | 0.100 |
Why?
|
Cell Culture Techniques | 3 | 2009 | 1669 | 0.100 |
Why?
|
Biophysics | 1 | 2013 | 379 | 0.100 |
Why?
|
Pelvis | 1 | 2016 | 737 | 0.100 |
Why?
|
Fibrosis | 4 | 2023 | 2076 | 0.100 |
Why?
|
Preoperative Care | 1 | 2021 | 2257 | 0.100 |
Why?
|
Pneumonectomy | 3 | 2023 | 1159 | 0.100 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2011 | 59 | 0.100 |
Why?
|
United States | 11 | 2024 | 73120 | 0.100 |
Why?
|
Checklist | 3 | 2019 | 843 | 0.090 |
Why?
|
Lymphangiogenesis | 2 | 2023 | 172 | 0.090 |
Why?
|
Cooperative Behavior | 2 | 2016 | 1514 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1816 | 0.090 |
Why?
|
Gene Expression Regulation | 6 | 2016 | 11928 | 0.090 |
Why?
|
Air Pressure | 1 | 2011 | 75 | 0.090 |
Why?
|
Diaphragm | 1 | 2013 | 360 | 0.090 |
Why?
|
Quality Assurance, Health Care | 2 | 2013 | 2179 | 0.090 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5891 | 0.090 |
Why?
|
Protein Denaturation | 3 | 2005 | 242 | 0.090 |
Why?
|
Terrorism | 1 | 2013 | 211 | 0.090 |
Why?
|
Cell Degranulation | 1 | 2011 | 277 | 0.090 |
Why?
|
Myofibroblasts | 1 | 2012 | 232 | 0.090 |
Why?
|
Signal Transduction | 5 | 2021 | 23639 | 0.090 |
Why?
|
Serum Albumin | 2 | 2024 | 676 | 0.090 |
Why?
|
Abdomen | 1 | 2016 | 1136 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2465 | 0.090 |
Why?
|
Statistics, Nonparametric | 2 | 2017 | 2861 | 0.090 |
Why?
|
Oxygen | 2 | 2013 | 4269 | 0.090 |
Why?
|
Bone Regeneration | 1 | 2013 | 445 | 0.090 |
Why?
|
Linear Models | 2 | 2013 | 5880 | 0.090 |
Why?
|
Androgen Antagonists | 1 | 2019 | 1418 | 0.090 |
Why?
|
Blast Injuries | 1 | 2013 | 324 | 0.090 |
Why?
|
Biopsy | 4 | 2024 | 6816 | 0.090 |
Why?
|
Migraine Disorders | 1 | 2022 | 1713 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 3105 | 0.080 |
Why?
|
Irritants | 1 | 2009 | 43 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2019 | 1600 | 0.080 |
Why?
|
Internet | 1 | 2002 | 3123 | 0.080 |
Why?
|
Prognosis | 6 | 2019 | 30031 | 0.080 |
Why?
|
Physical Therapy Modalities | 1 | 2013 | 533 | 0.080 |
Why?
|
Hyperemia | 1 | 2011 | 225 | 0.080 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2010 | 225 | 0.080 |
Why?
|
Biofilms | 1 | 2014 | 634 | 0.080 |
Why?
|
Dioxoles | 1 | 2009 | 96 | 0.080 |
Why?
|
Tetrahydroisoquinolines | 1 | 2009 | 81 | 0.080 |
Why?
|
K562 Cells | 2 | 2021 | 645 | 0.080 |
Why?
|
Immunosuppressive Agents | 2 | 2019 | 4213 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2020 | 3145 | 0.080 |
Why?
|
Muscle, Skeletal | 2 | 2004 | 4984 | 0.080 |
Why?
|
Massachusetts | 2 | 2018 | 8905 | 0.080 |
Why?
|
Cell Movement | 4 | 2019 | 5223 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2019 | 3234 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2723 | 0.080 |
Why?
|
Hysterectomy | 1 | 2014 | 863 | 0.080 |
Why?
|
Skin Diseases | 1 | 2017 | 1099 | 0.080 |
Why?
|
Fasciitis, Necrotizing | 1 | 2009 | 79 | 0.080 |
Why?
|
Multicenter Studies as Topic | 2 | 2024 | 1727 | 0.080 |
Why?
|
Mice, Nude | 3 | 2019 | 3635 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2022 | 1794 | 0.080 |
Why?
|
Medical Staff, Hospital | 1 | 2012 | 603 | 0.080 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2022 | 475 | 0.080 |
Why?
|
Soft Tissue Neoplasms | 2 | 2012 | 1166 | 0.070 |
Why?
|
Upper Extremity | 2 | 2012 | 683 | 0.070 |
Why?
|
Physician Incentive Plans | 1 | 2009 | 164 | 0.070 |
Why?
|
Otolaryngology | 1 | 2015 | 698 | 0.070 |
Why?
|
Disaster Planning | 1 | 2013 | 560 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2011 | 3697 | 0.070 |
Why?
|
Dimethyl Sulfoxide | 1 | 2008 | 252 | 0.070 |
Why?
|
Cryoprotective Agents | 1 | 2008 | 128 | 0.070 |
Why?
|
Teaching | 1 | 2015 | 1174 | 0.070 |
Why?
|
Incidence | 4 | 2023 | 21552 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2017 | 9425 | 0.070 |
Why?
|
Cell Count | 2 | 2014 | 1834 | 0.070 |
Why?
|
Orthopedics | 1 | 2016 | 906 | 0.070 |
Why?
|
Hospitals, Military | 1 | 2007 | 62 | 0.070 |
Why?
|
Pilot Projects | 4 | 2022 | 8730 | 0.070 |
Why?
|
Ear | 1 | 2007 | 172 | 0.070 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2009 | 692 | 0.070 |
Why?
|
Laser Therapy | 1 | 2014 | 1107 | 0.070 |
Why?
|
Radiography | 2 | 2016 | 6995 | 0.070 |
Why?
|
Breast Implantation | 2 | 2024 | 224 | 0.070 |
Why?
|
Quality Control | 2 | 2020 | 835 | 0.070 |
Why?
|
Photomicrography | 1 | 2006 | 72 | 0.070 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 895 | 0.070 |
Why?
|
Rats, Wistar | 2 | 2007 | 1891 | 0.070 |
Why?
|
Acute Disease | 3 | 2021 | 7245 | 0.070 |
Why?
|
Sciatic Neuropathy | 1 | 2007 | 76 | 0.070 |
Why?
|
Ticlopidine | 1 | 2011 | 730 | 0.070 |
Why?
|
Patient Readmission | 2 | 2024 | 3308 | 0.070 |
Why?
|
Organizations, Nonprofit | 1 | 2007 | 105 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4266 | 0.070 |
Why?
|
Microvessels | 1 | 2011 | 586 | 0.070 |
Why?
|
Vietnam | 1 | 2007 | 416 | 0.070 |
Why?
|
Fasciitis | 1 | 2007 | 67 | 0.070 |
Why?
|
Sarcoma | 2 | 2012 | 1806 | 0.060 |
Why?
|
DNA Primers | 1 | 2010 | 2825 | 0.060 |
Why?
|
Macrophages | 2 | 2018 | 5797 | 0.060 |
Why?
|
Receptors, CXCR4 | 1 | 2010 | 728 | 0.060 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 425 | 0.060 |
Why?
|
Peripheral Vascular Diseases | 1 | 2008 | 489 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2016 | 22286 | 0.060 |
Why?
|
North America | 2 | 2019 | 1292 | 0.060 |
Why?
|
Microfluidics | 1 | 2010 | 675 | 0.060 |
Why?
|
Burn Units | 1 | 2006 | 143 | 0.060 |
Why?
|
Chemical Phenomena | 2 | 2012 | 486 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2006 | 254 | 0.060 |
Why?
|
Sulfonamides | 1 | 2014 | 1988 | 0.060 |
Why?
|
Body Mass Index | 2 | 2024 | 13030 | 0.060 |
Why?
|
Urban Health Services | 1 | 2006 | 177 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2002 | 9066 | 0.060 |
Why?
|
Protein Folding | 2 | 2005 | 875 | 0.060 |
Why?
|
Glycoproteins | 1 | 2012 | 2207 | 0.060 |
Why?
|
Surgical Instruments | 1 | 2007 | 386 | 0.060 |
Why?
|
Patient Discharge | 3 | 2024 | 3471 | 0.060 |
Why?
|
Up-Regulation | 2 | 2011 | 4132 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3530 | 0.060 |
Why?
|
Pyrazoles | 1 | 2014 | 2024 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4779 | 0.060 |
Why?
|
Depression | 1 | 2024 | 8235 | 0.060 |
Why?
|
Adolescent | 11 | 2016 | 89163 | 0.060 |
Why?
|
Cellulitis | 1 | 2006 | 209 | 0.060 |
Why?
|
Cells | 1 | 2005 | 166 | 0.060 |
Why?
|
Postoperative Period | 2 | 2018 | 1833 | 0.060 |
Why?
|
Head and Neck Neoplasms | 2 | 2015 | 2915 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2016 | 3484 | 0.060 |
Why?
|
Fellowships and Scholarships | 1 | 2012 | 1134 | 0.060 |
Why?
|
Liver Function Tests | 1 | 2005 | 527 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2010 | 887 | 0.050 |
Why?
|
Comprehension | 1 | 2009 | 641 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 2705 | 0.050 |
Why?
|
Canada | 2 | 2019 | 2143 | 0.050 |
Why?
|
Cryopreservation | 1 | 2008 | 731 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2016 | 1881 | 0.050 |
Why?
|
Evans Blue | 1 | 2023 | 42 | 0.050 |
Why?
|
Craniocerebral Trauma | 1 | 2007 | 496 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3543 | 0.050 |
Why?
|
Capillaries | 1 | 2006 | 756 | 0.050 |
Why?
|
Blood Vessels | 1 | 2008 | 1112 | 0.050 |
Why?
|
Limb Salvage | 1 | 2006 | 489 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2022 | 12813 | 0.050 |
Why?
|
Collateral Circulation | 1 | 2004 | 293 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2005 | 1435 | 0.050 |
Why?
|
Reference Values | 2 | 2019 | 4941 | 0.050 |
Why?
|
Cell Line | 3 | 2021 | 15610 | 0.050 |
Why?
|
Angiography | 1 | 2008 | 1597 | 0.050 |
Why?
|
Cell Adhesion Molecules | 1 | 2008 | 1615 | 0.050 |
Why?
|
Cell Survival | 3 | 2017 | 5800 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12096 | 0.050 |
Why?
|
Ischemia | 2 | 2022 | 1900 | 0.050 |
Why?
|
Contracture | 2 | 2007 | 236 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2018 | 6856 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4294 | 0.050 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2010 | 631 | 0.050 |
Why?
|
Computer Simulation | 3 | 2005 | 6278 | 0.050 |
Why?
|
Chondroitin Sulfates | 1 | 2001 | 174 | 0.050 |
Why?
|
Suture Techniques | 2 | 2010 | 776 | 0.050 |
Why?
|
Algorithms | 3 | 2014 | 14157 | 0.050 |
Why?
|
Integrins | 2 | 2013 | 845 | 0.050 |
Why?
|
Instillation, Drug | 1 | 2021 | 32 | 0.050 |
Why?
|
Educational Measurement | 1 | 2008 | 1256 | 0.050 |
Why?
|
Glass | 1 | 2021 | 116 | 0.050 |
Why?
|
Ulcer | 1 | 2022 | 204 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2016 | 3439 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 8051 | 0.050 |
Why?
|
PPAR gamma | 1 | 2023 | 487 | 0.050 |
Why?
|
Sus scrofa | 2 | 2014 | 430 | 0.050 |
Why?
|
Bacterial Infections | 1 | 2009 | 1397 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 26348 | 0.040 |
Why?
|
Program Development | 1 | 2007 | 1296 | 0.040 |
Why?
|
Proteins | 2 | 2005 | 6009 | 0.040 |
Why?
|
International Cooperation | 1 | 2007 | 1439 | 0.040 |
Why?
|
Quality Indicators, Health Care | 3 | 2016 | 1813 | 0.040 |
Why?
|
Phototherapy | 1 | 2023 | 369 | 0.040 |
Why?
|
RNA | 1 | 2010 | 2728 | 0.040 |
Why?
|
Internship and Residency | 2 | 2012 | 5952 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2022 | 5308 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2012 | 2411 | 0.040 |
Why?
|
Data Collection | 1 | 2009 | 3329 | 0.040 |
Why?
|
Age Factors | 3 | 2018 | 18477 | 0.040 |
Why?
|
Electric Injuries | 1 | 1999 | 24 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13589 | 0.040 |
Why?
|
Biology | 1 | 2022 | 291 | 0.040 |
Why?
|
Learning | 1 | 2009 | 1762 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3813 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 2 | 2004 | 4077 | 0.040 |
Why?
|
Thermodynamics | 3 | 2005 | 594 | 0.040 |
Why?
|
Neoplasms | 1 | 2008 | 22389 | 0.040 |
Why?
|
Survival Analysis | 2 | 2017 | 10127 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2002 | 1629 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2020 | 9558 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2006 | 1660 | 0.040 |
Why?
|
Hodgkin Disease | 1 | 2007 | 1386 | 0.040 |
Why?
|
Base Sequence | 1 | 2010 | 12426 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2016 | 2477 | 0.040 |
Why?
|
Prosthesis-Related Infections | 2 | 2008 | 491 | 0.040 |
Why?
|
Mice, Knockout | 1 | 2014 | 14483 | 0.040 |
Why?
|
Methacrylates | 1 | 2019 | 110 | 0.040 |
Why?
|
Bacteremia | 1 | 2006 | 985 | 0.040 |
Why?
|
Integrin alpha6beta4 | 1 | 1998 | 31 | 0.040 |
Why?
|
Gene Expression | 2 | 2023 | 7605 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2001 | 716 | 0.040 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2019 | 185 | 0.040 |
Why?
|
Program Evaluation | 1 | 2007 | 2508 | 0.040 |
Why?
|
Anti-Infective Agents, Local | 1 | 2021 | 248 | 0.040 |
Why?
|
3T3 Cells | 1 | 2020 | 1086 | 0.040 |
Why?
|
Tissue Transplantation | 1 | 2019 | 128 | 0.040 |
Why?
|
Chemistry, Physical | 1 | 1998 | 153 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9508 | 0.040 |
Why?
|
Laparoscopy | 1 | 2010 | 2056 | 0.040 |
Why?
|
Injections, Intralesional | 1 | 2019 | 281 | 0.040 |
Why?
|
Mice, Obese | 1 | 2018 | 418 | 0.040 |
Why?
|
Protein Conformation | 1 | 2005 | 3972 | 0.040 |
Why?
|
Culture Techniques | 1 | 1998 | 530 | 0.040 |
Why?
|
Transillumination | 1 | 2017 | 20 | 0.040 |
Why?
|
Ultrasonography | 2 | 2015 | 5994 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 557 | 0.040 |
Why?
|
Organ Culture Techniques | 1 | 2020 | 796 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15965 | 0.040 |
Why?
|
Tissue Adhesives | 1 | 2019 | 179 | 0.040 |
Why?
|
Phospholipids | 1 | 2021 | 783 | 0.040 |
Why?
|
Viscosity | 1 | 1998 | 336 | 0.040 |
Why?
|
Neck Injuries | 1 | 1999 | 163 | 0.040 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2018 | 169 | 0.040 |
Why?
|
Blood Glucose | 2 | 2022 | 6429 | 0.030 |
Why?
|
Carotid Artery Injuries | 1 | 1997 | 96 | 0.030 |
Why?
|
Health Services | 1 | 2002 | 756 | 0.030 |
Why?
|
Laminin | 1 | 1998 | 407 | 0.030 |
Why?
|
Penis | 1 | 1997 | 213 | 0.030 |
Why?
|
Liver Diseases | 1 | 2005 | 1307 | 0.030 |
Why?
|
Empyema, Pleural | 1 | 1997 | 62 | 0.030 |
Why?
|
Immunomodulation | 1 | 2020 | 550 | 0.030 |
Why?
|
Cattle | 2 | 2001 | 3830 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2023 | 2730 | 0.030 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2016 | 48 | 0.030 |
Why?
|
Models, Biological | 4 | 2007 | 9505 | 0.030 |
Why?
|
Replantation | 1 | 1997 | 145 | 0.030 |
Why?
|
Amputation, Traumatic | 1 | 1997 | 135 | 0.030 |
Why?
|
Factor VIII | 1 | 1998 | 349 | 0.030 |
Why?
|
Journal Impact Factor | 1 | 2017 | 154 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2004 | 3637 | 0.030 |
Why?
|
Hypopharyngeal Neoplasms | 1 | 2015 | 52 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2021 | 1247 | 0.030 |
Why?
|
Placebos | 1 | 2000 | 1668 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20232 | 0.030 |
Why?
|
Tropical Climate | 1 | 1995 | 35 | 0.030 |
Why?
|
Muscle Strength | 1 | 2019 | 641 | 0.030 |
Why?
|
Lymphangioma, Cystic | 1 | 1995 | 34 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2022 | 5371 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 621 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2016 | 319 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2003 | 1602 | 0.030 |
Why?
|
Complementary Therapies | 1 | 2019 | 487 | 0.030 |
Why?
|
Fracture Healing | 1 | 1998 | 448 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2298 | 0.030 |
Why?
|
Half-Life | 1 | 2016 | 650 | 0.030 |
Why?
|
Hyperplasia | 1 | 1998 | 1154 | 0.030 |
Why?
|
Bone Development | 1 | 1998 | 473 | 0.030 |
Why?
|
Facial Bones | 1 | 1996 | 209 | 0.030 |
Why?
|
Child, Preschool | 6 | 2023 | 42620 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2268 | 0.030 |
Why?
|
Stevens-Johnson Syndrome | 1 | 1997 | 246 | 0.030 |
Why?
|
Health Surveys | 1 | 2024 | 4056 | 0.030 |
Why?
|
Comorbidity | 1 | 2009 | 10601 | 0.030 |
Why?
|
Dermatology | 1 | 2024 | 920 | 0.030 |
Why?
|
Protein Precursors | 1 | 1998 | 1133 | 0.030 |
Why?
|
Antigens, Surface | 1 | 1998 | 1615 | 0.030 |
Why?
|
Ultrasonics | 1 | 2015 | 208 | 0.030 |
Why?
|
Pneumonia | 2 | 2016 | 2162 | 0.030 |
Why?
|
Mammography | 1 | 2004 | 2436 | 0.030 |
Why?
|
Language | 1 | 2022 | 1557 | 0.030 |
Why?
|
Carotid Arteries | 1 | 1997 | 943 | 0.030 |
Why?
|
Bursitis | 1 | 1994 | 85 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1650 | 0.030 |
Why?
|
Shoulder | 1 | 1995 | 301 | 0.030 |
Why?
|
Fibrosarcoma | 1 | 1995 | 313 | 0.030 |
Why?
|
Constriction | 1 | 2012 | 168 | 0.030 |
Why?
|
Cysts | 1 | 1998 | 685 | 0.030 |
Why?
|
Transient Receptor Potential Channels | 1 | 2013 | 130 | 0.030 |
Why?
|
Human Growth Hormone | 1 | 1997 | 648 | 0.020 |
Why?
|
Energy Intake | 1 | 2000 | 2141 | 0.020 |
Why?
|
Extremities | 1 | 1997 | 870 | 0.020 |
Why?
|
Axilla | 1 | 1995 | 629 | 0.020 |
Why?
|
Myositis | 1 | 1995 | 278 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 1997 | 821 | 0.020 |
Why?
|
Gap Junctions | 1 | 2013 | 230 | 0.020 |
Why?
|
Laryngeal Neoplasms | 1 | 2015 | 515 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2013 | 501 | 0.020 |
Why?
|
Thorax | 1 | 1995 | 559 | 0.020 |
Why?
|
Metaplasia | 1 | 2012 | 326 | 0.020 |
Why?
|
Liver | 2 | 2014 | 7575 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1609 | 0.020 |
Why?
|
Psychometrics | 1 | 2021 | 3072 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12561 | 0.020 |
Why?
|
Facial Expression | 1 | 1995 | 515 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 1997 | 1107 | 0.020 |
Why?
|
Physicians | 1 | 2009 | 4615 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4040 | 0.020 |
Why?
|
Palliative Care | 1 | 2006 | 3644 | 0.020 |
Why?
|
Fruit | 1 | 1996 | 1165 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2011 | 753 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2103 | 0.020 |
Why?
|
Duodenoscopy | 1 | 2010 | 45 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2015 | 11249 | 0.020 |
Why?
|
Rosacea | 1 | 2011 | 60 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2021 | 5490 | 0.020 |
Why?
|
Boston | 2 | 2013 | 9359 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2019 | 6241 | 0.020 |
Why?
|
Muscle Contraction | 1 | 1995 | 1208 | 0.020 |
Why?
|
Cadaver | 1 | 1994 | 1362 | 0.020 |
Why?
|
Proteome | 1 | 2020 | 1881 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2014 | 771 | 0.020 |
Why?
|
Muscles | 1 | 1994 | 1582 | 0.020 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2015 | 493 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4613 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2014 | 1337 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 2016 | 806 | 0.020 |
Why?
|
Benchmarking | 1 | 2016 | 1058 | 0.020 |
Why?
|
Risk Adjustment | 1 | 2013 | 603 | 0.020 |
Why?
|
Cell Transdifferentiation | 1 | 2010 | 188 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2994 | 0.020 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2009 | 101 | 0.020 |
Why?
|
Causality | 1 | 2015 | 1255 | 0.020 |
Why?
|
Child | 6 | 2016 | 80856 | 0.020 |
Why?
|
Cilia | 1 | 2013 | 501 | 0.020 |
Why?
|
Anxiety | 1 | 2024 | 4655 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2819 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6320 | 0.020 |
Why?
|
Gastroscopy | 1 | 2010 | 213 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1997 | 2201 | 0.020 |
Why?
|
Cervicoplasty | 1 | 2007 | 8 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8331 | 0.020 |
Why?
|
Heart-Assist Devices | 1 | 1998 | 1292 | 0.020 |
Why?
|
Licensure, Medical | 1 | 2008 | 72 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2020 | 3076 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2238 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2019 | 8201 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2014 | 1487 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15879 | 0.020 |
Why?
|
Bone and Bones | 1 | 1998 | 2589 | 0.020 |
Why?
|
Cardiopulmonary Bypass | 1 | 2012 | 1097 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5096 | 0.020 |
Why?
|
Health Personnel | 1 | 2021 | 3384 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2002 | 4340 | 0.020 |
Why?
|
Transgenes | 1 | 2010 | 1015 | 0.020 |
Why?
|
Erythrocyte Transfusion | 1 | 2011 | 574 | 0.020 |
Why?
|
Nutritional Physiological Phenomena | 1 | 1988 | 361 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6353 | 0.020 |
Why?
|
Fetus | 1 | 2014 | 1883 | 0.020 |
Why?
|
Growth Substances | 1 | 1988 | 761 | 0.020 |
Why?
|
Growth Hormone | 1 | 1988 | 573 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3901 | 0.020 |
Why?
|
Models, Theoretical | 1 | 1998 | 3590 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 1995 | 1412 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2000 | 12450 | 0.020 |
Why?
|
Models, Educational | 1 | 2008 | 375 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2009 | 618 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3832 | 0.020 |
Why?
|
Accreditation | 1 | 2008 | 478 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36840 | 0.010 |
Why?
|
Microscopy | 1 | 2010 | 909 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2228 | 0.010 |
Why?
|
Solutions | 1 | 2005 | 411 | 0.010 |
Why?
|
DNA Methylation | 1 | 2019 | 4425 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2072 | 0.010 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 530 | 0.010 |
Why?
|
Mathematics | 1 | 2005 | 704 | 0.010 |
Why?
|
Device Removal | 1 | 2009 | 641 | 0.010 |
Why?
|
Heart Arrest | 1 | 2014 | 1516 | 0.010 |
Why?
|
Myocardial Infarction | 2 | 2016 | 11515 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2009 | 749 | 0.010 |
Why?
|
Glucose | 1 | 2016 | 4355 | 0.010 |
Why?
|
Genes | 1 | 2007 | 1824 | 0.010 |
Why?
|
Hemorrhage | 1 | 2016 | 3456 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5532 | 0.010 |
Why?
|
Drainage | 1 | 2009 | 1180 | 0.010 |
Why?
|
Models, Chemical | 1 | 2005 | 611 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 635 | 0.010 |
Why?
|
Lipid Bilayers | 1 | 2005 | 379 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5367 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8636 | 0.010 |
Why?
|
Colonoscopy | 1 | 2010 | 1412 | 0.010 |
Why?
|
Leiomyoma | 1 | 2006 | 641 | 0.010 |
Why?
|
Insulin | 1 | 2016 | 6606 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2012 | 2896 | 0.010 |
Why?
|
Bronchoscopy | 1 | 2007 | 913 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 2008 | 986 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15459 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4022 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2005 | 1337 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5709 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 2942 | 0.010 |
Why?
|
Water | 1 | 2005 | 1421 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3793 | 0.010 |
Why?
|
Membranes, Artificial | 1 | 1981 | 367 | 0.010 |
Why?
|
Mitochondrial Proteins | 1 | 2005 | 979 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2007 | 1760 | 0.010 |
Why?
|
Deceleration | 1 | 1997 | 10 | 0.010 |
Why?
|
Uterine Neoplasms | 1 | 2006 | 1423 | 0.010 |
Why?
|
Dermabrasion | 1 | 1997 | 17 | 0.010 |
Why?
|
Seat Belts | 1 | 1997 | 60 | 0.010 |
Why?
|
Amputation Stumps | 1 | 1997 | 38 | 0.010 |
Why?
|
Tissue Survival | 1 | 1997 | 120 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14766 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 13045 | 0.010 |
Why?
|
Maxillary Fractures | 1 | 1996 | 21 | 0.010 |
Why?
|
Zygomatic Fractures | 1 | 1996 | 35 | 0.010 |
Why?
|
Microscopy, Electron | 2 | 1990 | 2565 | 0.010 |
Why?
|
Palate, Hard | 1 | 1996 | 59 | 0.010 |
Why?
|
Aortography | 1 | 1997 | 422 | 0.010 |
Why?
|
Models, Molecular | 1 | 2005 | 5441 | 0.010 |
Why?
|
Fractures, Comminuted | 1 | 1996 | 57 | 0.010 |
Why?
|
Homeostasis | 1 | 2006 | 3351 | 0.010 |
Why?
|
Suppuration | 1 | 1995 | 61 | 0.010 |
Why?
|
Mandibular Fractures | 1 | 1996 | 77 | 0.010 |
Why?
|
Orbital Fractures | 1 | 1996 | 109 | 0.010 |
Why?
|
Alveolar Process | 1 | 1996 | 294 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16712 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1996 | 20763 | 0.010 |
Why?
|
Veins | 1 | 1997 | 767 | 0.010 |
Why?
|
Parenteral Nutrition | 1 | 1997 | 663 | 0.010 |
Why?
|
Fatal Outcome | 1 | 1997 | 1841 | 0.010 |
Why?
|
Models, Anatomic | 1 | 1996 | 684 | 0.010 |
Why?
|
Nose | 1 | 1996 | 524 | 0.010 |
Why?
|
Arm | 1 | 1995 | 590 | 0.010 |
Why?
|
Bone Transplantation | 1 | 1996 | 925 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2007 | 6657 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2005 | 5808 | 0.010 |
Why?
|
Biodegradation, Environmental | 1 | 1990 | 221 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2007 | 6400 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 1994 | 952 | 0.000 |
Why?
|
Membrane Proteins | 1 | 2005 | 7895 | 0.000 |
Why?
|
Morphogenesis | 1 | 1989 | 747 | 0.000 |
Why?
|
Endoscopy | 1 | 1994 | 1857 | 0.000 |
Why?
|
Infant | 2 | 1997 | 36496 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1995 | 13025 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1997 | 26394 | 0.000 |
Why?
|